Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Diabetes

Free Subscription Articles published in Am J Kidney Dis Retrieve available abstracts of 17 articles: HTML format

Single Articles

April 2026
1. MALIJAN GB, Sardell RJ, Staplin N, Devuyst O, et al
   Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
   Am J Kidney Dis. 2026;87:553-563.
   PubMed     Abstract available
   
   
   March 2026
2. LEEHEY DJ, Agarwal R
   Is There a Role for Pentoxifylline in Diabetic Kidney Disease?
   Am J Kidney Dis. 2026 Mar 20:S0272-6386(26)00753.
   PubMed     Abstract available
   
   
   
3. MOTTL AK, Sawinski DL, Bjornstad P
   Kidney and Cardiovascular Protection in Diabetes: Beyond Diabetes Typology.
   Am J Kidney Dis. 2026 Mar 4:S0272-6386(26)00728.
   PubMed     Abstract available
   
   
   February 2026
4. YAU K, Ray JG, Jeyakumar N, Luo B, et al
   Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKD.
   Am J Kidney Dis. 2026;87:211-229.
   PubMed     Abstract available
   
   
   July 2025
5. TAAL MW, Eldehni MT, Selby NM
   Kidney Protective Effects of Glucagon-Like Peptide-1 Receptor Agonists Versus Sodium/Glucose Cotransporter 2 Inhibitors in Persons With Diabetes and CKD: Implications for Personalized Medicine.
   Am J Kidney Dis. 2025 Jul 17:S0272-6386(25)00912.
   PubMed    
   
   
   April 2025
6. LEE YC, Wu LC, Wu VC, Chang CH, et al
   Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists and Sodium/Glucose Cotransporter 2 Inhibitors in Preventing Chronic Kidney Failure and Mortality in Patients With Type 2 Diabetes and CKD.
   Am J Kidney Dis. 2025 Apr 29:S0272-6386(25)00831.
   PubMed     Abstract available
   
   
   
7. KANG MW, Oh JI, Lee J, Kim M, et al
   Longitudinal Income Dynamics and Risk of End-Stage Kidney Disease in Type 2 Diabetes: A South Korean Population-Based Cohort Study.
   Am J Kidney Dis. 2025 Apr 23:S0272-6386(25)00825.
   PubMed     Abstract available
   
   
   February 2025
8. LAMBOURG EJ, Fu EL, McGurnaghan S, Conway BR, et al
   Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study.
   Am J Kidney Dis. 2025;85:196-204.
   PubMed     Abstract available
   
   
   December 2024
9. SHIN JI, Creon A, Carrero JJ
   Metformin in People With Diabetes and Advanced CKD: Should We Dare?
   Am J Kidney Dis. 2024 Dec 10:S0272-6386(24)01053.
   PubMed    
   
   
   November 2024
10. PUZANTIAN H, Townsend RR
    Three Ankle-Brachial Index Ranges and Incident CKD in Diabetes: A Goldilocks Perspective on the "Just Right" Range.
    Am J Kidney Dis. 2024 Nov 20:S0272-6386(24)00994.
    PubMed    
    
    
    September 2024
11. LIU M, Zhang Y, Zhang Y, He P, et al
    Longitudinal Patterns of Ankle-Brachial Index and Their Association With Progression of CKD in Patients With Type 2 Diabetes and Elevated Body Mass Index.
    Am J Kidney Dis. 2024 Sep 30:S0272-6386(24)00980.
    PubMed     Abstract available
    
    
    July 2024
12. SHULMAN RS, Yang W, Cohen DL, Reese PP, et al
    Cardiovascular and Kidney Outcomes of Non-Diabetic CKD by Albuminuria Severity: Findings From the CRIC Study.
    Am J Kidney Dis. 2024 Jul 18:S0272-6386(24)00869.
    PubMed     Abstract available
    
    
    June 2024
13. LIANG YY, He Y, Wang J, Liu Y, et al
    Social Isolation, Loneliness, and Risk of Microvascular Complications Among Individuals With Type 2 Diabetes Mellitus.
    Am J Kidney Dis. 2024 Jun 24:S0272-6386(24)00839.
    PubMed     Abstract available
    
    
    May 2024
14. SHAH CV, Sparks MA, Lee CT
    Sodium/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis: A Review.
    Am J Kidney Dis. 2024;83:648-658.
    PubMed     Abstract available
    
    
    April 2024
15. CLAUDEL SE, Waikar SS
    Imprecise, Measure it Twice? Dealing With the Biological Variability of Albuminuria in Diabetes.
    Am J Kidney Dis. 2024 Apr 23:S0272-6386(24)00659.
    PubMed    
    
    
    March 2024
16. RASARATNAM N, Salim A, Blackberry I, Cooper ME, et al
    Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications.
    Am J Kidney Dis. 2024 Mar 15:S0272-6386(24)00620.
    PubMed     Abstract available
    
    
    November 2023
17. MORTON JI, Carstensen B, McDonald SP, Polkinghorne KR, et al
    Trends in the Incidence of End-Stage Kidney Disease in Type 1 and Type 2 Diabetes in Australia, 2010-2019.
    Am J Kidney Dis. 2023;82:608-616.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum